Product Information
ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) is a generic product labeled by Fresenius Kabi USA, LLC, priced at $2.1633 per ML under NDC 63323069444. Its NADAC has been published 216 times since Aug 4, 2021.
FDA first approved this application on Jun 21, 2012. Its Orange Book therapeutic-equivalence code is AN.
Strength
200 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323069444
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL; RESPIRATORY (INHALATION)
Effective Date
8/19/2026
Active Ingredients
ACETYLCYSTEINEApproval Type
Generic (ANDA)
FDA Application
ANDA203853FDA Approved
6/21/2012
TE Code
AN
On Market Since
9/1/2012
Pharmacological Classes
Price Statistics
The NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has been published 216 times since Aug 4, 2021, and over the history we have for it it has risen 31.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1633 per ML |
|---|---|
| All-time high | $2.6444 (Oct 15, 2025) |
| All-time low | $1.6443 (Aug 4, 2021) |
| 52-week high | $2.6444 |
| 52-week low | $2.1633 |
| Median price | $2.3452 |
| Average price | $2.1901 |
| Largest weekly change | +32.7% (Aug 23, 2023) |
| Weeks tracked | 216 |
| Tracking since | Aug 4, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 66% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
The current National Average Drug Acquisition Cost (NADAC) for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION), manufactured by Fresenius Kabi USA, LLC, is $2.1633 per ML (NDC 63323069444), effective Aug 19, 2026.
How has the price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) changed over time?
Over the history we have for it, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has risen 31.6%. It has been tracked across 216 weekly CMS publications since Aug 4, 2021.
What are the highest and lowest recorded NADAC prices for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
Since Aug 4, 2021, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has ranged from a low of $1.6443 (Aug 4, 2021) to a high of $2.6444 (Oct 15, 2025), with a median of $2.3452 per ML.
Are there cheaper alternatives to ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION), is $0.7413 per ML — about 66% below ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION).
Who manufactures ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) (NDC 63323069444) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.